![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Valvexchange, Inc. Greenwood Village Us, based in U.S.A, is a pharmaceutical company.
One of their significant offerings is Bovine pericardium, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2012-178 - Rev 00
This TSE Type CEP, issued on November 28, 2012, remains in force until December 15, 2017, ensuring its reliability within the pharmaceutical industry.